Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
sell

Akebia Therapeutics Inc. sell BiotechBee

Akebia Therapeutics Inc.
Start price
€1.51
17.03.24 / 60%
Target price
€0.30
30.11.25
Performance (%)
76.96%
End price
€2.67
28.03.24
Summary
This prediction ended on 28.03.24 with a price of €2.67. The price for Akebia Therapeutics Inc. massively increased, which is bad news for the SELL prediction by BiotechBee. BiotechBee has 60% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Akebia Therapeutics Inc. -3.127% -3.127% -23.404%
iShares Core DAX® 0.060% 1.215% 18.128%
iShares Nasdaq 100 -3.065% -0.519% 2.080%
iShares Nikkei 225® -2.094% -3.066% 11.655%
iShares S&P 500 -1.657% -0.069% 1.103%

According to BiotechBee what are the pros and cons of Akebia Therapeutics Inc. for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Akebia Therapeutics Inc. diskutieren
Prediction Sell
Perf. (%) 76.96%
Target price 0.300
Change
Ends at 30.11.25

Sell mit Kursziel 0,3

BiotechBee 
0
Report Share
17.03.24
In the thread Trading Akebia Therapeutics Inc.
Prediction Sell
Perf. (%) 76.96%
Target price 0.300
Change
Ends at 30.11.25

Sell beendet

BiotechBee 
0
Report Share
28.03.24